Cargando…

Smoking: Is it a risk factor for pulmonary vascular diseases?

Detalles Bibliográficos
Autores principales:	Weissmann, Norbert, Grimminger, Friedrich, Seeger, Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555409/ https://www.ncbi.nlm.nih.gov/pubmed/23372923 http://dx.doi.org/10.4103/2045-8932.105027

Ejemplares similares

Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling
por: Tian, Xia, et al.
Publicado: (2011)

Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice
por: Seimetz, Michael, et al.
Publicado: (2015)

Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration
por: Pullamsetti, Soni, et al.
Publicado: (2005)

Effects of riociguat in severe experimental pulmonary hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2011)

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2019)

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β
por: Dahal, Bhola K., et al.
Publicado: (2011)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2018)

Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
por: Gierhardt, Mareike, et al.
Publicado: (2021)

Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2022)

Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
por: Veeroju, Swathi, et al.
Publicado: (2021)

Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6
por: Fuchs, Beate, et al.
Publicado: (2011)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
por: Schermuly, Ralph Theo, et al.
Publicado: (2005)

The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats
por: Lang, Michaela, et al.
Publicado: (2011)

Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction
por: Ketabchi, Farzaneh, et al.
Publicado: (2012)

Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension
por: Sklepkiewicz, Piotr, et al.
Publicado: (2011)

Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction
por: Egemnazarov, Bakytbek, et al.
Publicado: (2010)

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice
por: Gredic, Marija, et al.
Publicado: (2022)

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
por: Udalov, Sergey, et al.
Publicado: (2010)

Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice
por: Hadzic, Stefan, et al.
Publicado: (2023)

Improvement of right heart structure and function by BAY 41-8543 in pulmonary artery banded mice
por: Janssen, Wiebke, et al.
Publicado: (2011)

The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
por: Lang, Michaela, et al.
Publicado: (2012)

Correction: Improvement of right heart structure and function by BAY41-8543 in pulmonary artery banded mice
por: Janssen, Wiebke, et al.
Publicado: (2011)

Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
por: Udalov, Sergey, et al.
Publicado: (2022)

sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung
por: Egemnazarov, Bakytbek, et al.
Publicado: (2009)

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2010)

IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension
por: Biswas, Siladitta, et al.
Publicado: (2020)

Correction to: Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2022)

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Dabral, Swati, et al.
Publicado: (2019)

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
por: Dahal, Bhola K, et al.
Publicado: (2011)

Adenylate Kinase 4—A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways
por: Wujak, Magdalena, et al.
Publicado: (2021)

A novel noninvasive method for estimating right ventricular systolic pressure in rodents with pulmonary artery banding
por: Kojonazarov, Baktybek, et al.
Publicado: (2023)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)

Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension
por: Amirjanians, Matthieu, et al.
Publicado: (2017)

Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular tone
por: Gierhardt, Mareike, et al.
Publicado: (2020)

Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury
por: Dumitrascu, Rio, et al.
Publicado: (2008)

Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension
por: Thamm, Melanie, et al.
Publicado: (2011)

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
por: Weiss, Astrid, et al.
Publicado: (2019)

Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats
por: Mamazhakypov, Argen, et al.
Publicado: (2020)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
por: Schermuly, Ralph T, et al.
Publicado: (2007)

Deletion of classical transient receptor potential 1, 3 and 6 alters pulmonary vasoconstriction in chronic hypoxia-induced pulmonary hypertension in mice
por: Malkmus, Kathrin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l5d9s1ki65kn5m1oghnfjcerm3